Ignite Creation Date:
2024-05-06 @ 2:47 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04422912
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2020-06-02
Brief Title:
A Phase 12 Open-label Safety and Dosing Study of Autologous CART Cells Desmoglein 3 Chimeric Autoantibody Receptor T Cells DSG3-CAART or CD19-specific Chimeric Antigen Receptor T Cells CABA-201 in Subjects With Active Pemphigus Vulgaris RESET-PV
Sponsor:
Cabaletta Bio
Organization:
Cabaletta Bio
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-02
First Submit QC Date:
June 5 2020
Study First Post Date:
2020-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-21
Last Update Post Date:
2024-05-22
Last Update Post Date Type:
ACTUAL